BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Speck-Planche A, Kleandrova VV, Scotti MT. In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha. Biomolecules 2021;11:1832. [PMID: 34944476 DOI: 10.3390/biom11121832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fu C, Yu L, Miao Y, Liu X, Yu Z, Wei M. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope? Acta Pharm Sin B 2023;13:498-516. [PMID: 36873165 DOI: 10.1016/j.apsb.2022.07.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Speck-planche A, Kleandrova VV. Multi-Condition QSAR Model for the Virtual Design of Chemicals with Dual Pan-Antiviral and Anti-Cytokine Storm Profiles. ACS Omega. [DOI: 10.1021/acsomega.2c03363] [Reference Citation Analysis]
3 Halder AK, Moura AS, Cordeiro MNDS. Moving Average-Based Multitasking In Silico Classification Modeling: Where Do We Stand and What Is Next? Int J Mol Sci 2022;23:4937. [PMID: 35563327 DOI: 10.3390/ijms23094937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kleandrova VV, Speck-Planche A. PTML Modeling for Pancreatic Cancer Research: In Silico Design of Simultaneous Multi-Protein and Multi-Cell Inhibitors. Biomedicines 2022;10:491. [PMID: 35203699 DOI: 10.3390/biomedicines10020491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]